# On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

> **NCT02677974** · — · ACTIVE_NOT_RECRUITING · sponsor: **On-X Life Technologies, Inc.** · enrollment: 510 (actual)

## Conditions studied

- Thrombotic and Bleeding Events

## Interventions

- **DEVICE:** On-X Aortic Heart Valve replacement

## Key facts

- **NCT ID:** NCT02677974
- **Lead sponsor:** On-X Life Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-11-10
- **Primary completion:** 2027-04
- **Final completion:** 2027-08
- **Target enrollment:** 510 (ACTUAL)
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677974, "On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02677974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*